微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.17% | 19.39% | 63.41% | 77/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.72% | 2.29% | 101.61% | 75/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -44.51% | -5663.75% | -3550.39% | 127/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 1.29% | -21.34% | 31.63% | 91/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.98% | 218.07% | 40% | 87/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.7% | 333.33% | -12.5% | 82/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 0.8% | -20% | -51.22% | 92/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 1.64% | -74.77% | 297.59% | 92/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.83% | -147.43% | -176.67% | 113/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.3% | -124.19% | -130% | 110/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 1% | -56.71% | -84.62% | 99/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 6.5% | 52.94% | 271.43% | 51/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.75% | -25.85% | 41.13% | 89/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.24% | 18.1% | -46.32% | 78/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 2.31% | 10% | -45.65% | 108/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 4.25% | 19.05% | 80.08% | 89/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.36% | 34.09% | 124.76% | 93/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.05% | -16.67% | -50% | 86/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 2.1% | 250% | -41.18% | 116/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 3.57% | 457.81% | 102.84% | 97/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 1.76% | 1860% | 39.68% | 108/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.26% | 121.05% | 190% | 88/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -1.4% | 32.69% | -318.75% | 119/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 0.64% | -70.78% | 740% | 84/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | -0.1% | -107.63% | -117.54% | 103/141 | 15.17% | 杭州博拓生物科技 | 108.13% | 行业排名> |
| 2020-03-31 | 0.57% | -5% | 127.4% | 64/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -2.08% | -360% | -194.98% | 113/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 2.19% | -48.71% | 67.18% | 59/141 | 10.54% | 祥生医疗科技 | 28.56% | 行业排名> |
| 2019-06-30 | 1.31% | -48.22% | 118.33% | 66/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.6% | -68.59% | -25% | 48/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 0.8% | -89.61% | -81.26% | 99/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.27% | -48.18% | 68.77% | 45/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 2.53% | -44.76% | 32.46% | 45/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.91% | -23.9% | -75.19% | 33/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 7.7% | -11.7% | -6.55% | 73/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 8.24% | 7.99% | 79.91% | 25/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.58% | -12.6% | 82.47% | 35/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.51% | -16.33% | -71.22% | 19/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.72% | -32.92% | 14.29% | 56/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 7.63% | -49.07% | 45.61% | 18/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 5.24% | -49.52% | 74.67% | 27/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 3% | -41.86% | -76.92% | 11/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |